OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 85 filers reported holding OVID THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 6.38 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $66,163 | +19.1% | 17,230 | +1.8% | 0.00% | – |
| Q2 2023 | $55,530 | -36.2% | 16,930 | -22.1% | 0.00% | – |
| Q1 2021 | $87,000 | +74.0% | 21,739 | 0.0% | 0.00% | – |
| Q4 2020 | $50,000 | -60.0% | 21,739 | 0.0% | 0.00% | – |
| Q3 2020 | $125,000 | -21.9% | 21,739 | 0.0% | 0.00% | – |
| Q2 2020 | $160,000 | – | 21,739 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TLS Advisors LLC | 1,380,346 | $3,516 | 18.08% |
| Madison Avenue Partners, LP | 3,104,603 | $8,009,876 | 1.72% |
| BVF INC/IL | 6,851,051 | $17,675,712 | 0.65% |
| CHI Advisors LLC | 864,822 | $2,231,241 | 0.59% |
| EcoR1 Capital, LLC | 6,117,400 | $15,782,892 | 0.51% |
| Rubric Capital Management LP | 7,001,124 | $18,062,900 | 0.47% |
| Artal Group S.A. | 2,500,000 | $6,450 | 0.38% |
| Tejara Capital Ltd | 118,791 | $306,481 | 0.16% |
| DCF Advisers, LLC | 68,264 | $176,120 | 0.11% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 827,580 | $2,135,156 | 0.06% |